Page last updated: 2024-08-26

aldophosphamide and Leukemia P388

aldophosphamide has been researched along with Leukemia P388 in 2 studies

*Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Voelcker, G1
Maki, PA; Sladek, NE1

Other Studies

2 other study(ies) available for aldophosphamide and Leukemia P388

ArticleYear
Causes and possibilities to circumvent cyclophosphamide toxicity.
    Anti-cancer drugs, 2020, Volume: 31, Issue:6

    Topics: Animals; Antineoplastic Agents, Alkylating; Cell Proliferation; Cyclophosphamide; Female; Leukemia P388; Male; Mice; Phosphoramide Mustards; Toxicity Tests

2020
Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
    Cancer research, 1991, Aug-15, Volume: 51, Issue:16

    Topics: Aldehyde Dehydrogenase; Animals; Antineoplastic Agents; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Drug Synergism; Hematopoietic Stem Cells; Inactivation, Metabolic; Kinetics; Leukemia L1210; Leukemia P388; Male; Mice; Mice, Inbred BALB C; Phosphoramide Mustards; Procarbazine

1991